A New Dawn for Fragile Lives: Abeona Therapeutics' Zevaskyn Revenue Signals a Profound Shift

uniQure Soars: Mizuho Upgrade Rekindles Hope for Huntington's Gene Therapy

A Critical Eye on Progress: FDA Official Questions uniQure's Huntington's Trial Comparisons

The Shifting Sands of Pharma: FDA's Grip, Global Ambitions, and the Future of Medicine

A Major Setback: FDA Halts uniQure's Huntington's Gene Therapy Trial

Unlocking the Brain's Secrets: A New Dawn in the Fight Against Alzheimer's

The Million-Dollar Question: Unpacking the FDA Chief's Gene Therapy Warning

The End of an Era: Doug Ingram Prepares to Retire from Sarepta, Elizabeth Barrett Named Successor

Sana Biotechnology: A Deep Dive into a Speculative Biotech Bet

Why Did Regenxbio (RGNX) Shares Take Such a Steep Dive After Hours? Unpacking the Gene Therapy News

A Mother's Strength: Jesy Nelson Shares Daughter Alara's SMA Journey

BillionToOne: A Biotech Innovator Poised for a Breakthrough by 2026?

A Mother's Unwavering Fight for Her Daughter's Future

The Anticipation Builds: ASH 2025 and the Evolving Landscape of Blood Cancer Therapies

A Glimmer of Hope: CRISPR's Promise for Children with Pura Syndrome

A New Dawn for 'Bubble Babies': Revolutionary Gene Therapy Offers Full Immune Reboot

A Bold Bet on the Future: Regeneron's $150M Investment in Gene Writing

Quantum Leap for Life Sciences: IonQ and CCRM Team Up to Revolutionize Biotech and Medicine

Novartis Shares Soar as FDA Gives Landmark Nod to Zolgensma Gene Therapy for Teens and Adults

A Glimmer of Hope: World's First Gene Therapy Trial Fights Blindness

A Glimmer of Hope: Confronting Alzheimer's with Revolutionary Gene Therapy

The Quiet Hum of Hope and High Stakes: Unpacking the Future of Huntington's Treatment

The Quiet Revolution: How Sound Waves Are Rewriting the Future of Seizure Control

The Healing Frontier: Yzi Labs Dives Headfirst into Regenerative Medicine's Bold Promise

The Gene Therapy Dream Interrupted: UniQure Investors Face an Unsettling Inquiry

A Glimmer of Hope: Eli Lilly's Bold Leap into Gene Therapy for Blinding Eye Diseases

The End of the Needle? How Gene Therapy Could Turn Your Body into a GLP-1 Factory

The Pulse of Progress: Why Healthcare Stocks Are Sparking Investor Interest Right Now

A Glimmer of Hope: Tenaya Therapeutics Takes on Hypertrophic Cardiomyopathy with Bold New Gene Therapy

The CRISPR Revolution: A One-Time Fix for a Lifelong Problem? Unpacking the Future of Cholesterol Treatment

Krystal Biotech's Ascendant Star: Why William Blair Is Eyeing a Future of Sky-High Earnings

The FDA's Tightening Grip: A Crucible for Biotech's Biggest Bets

Navigating the Shifting Tides: A Look at Life Sciences in Q3 2025

A New Dawn in India's Cancer Fight: How Indigenous Gene Therapy is Rewriting the Rules of Hope

The Dawn of a New Era: India's Own Cancer Revolution Takes Hold

The Price of Hope: How Nexcar19 is Rewriting the Rules of Cancer Gene Therapy

A Whisper of Hope for the Heart: Tenaya's Gene Therapy Unveils Promising Data

The Heart of the Matter: A Gene Therapy's Bold Bid Against a Silent Killer

The High Stakes Game: Sarepta, Duchenne, and the Edge of Hope